Karachi: BF Biosciences Limited has announced that its Board of Directors will convene on September 28, 2026, at 17:00 via video link. The meeting aims to discuss the Annual Financial Results for the fiscal period ending on June 30, 2026, and to deliberate on any potential entitlements.

In compliance with regulatory requirements, the company has instituted a Closed Period starting from September 21, 2026, and extending through the day of the meeting on September 28, 2026. This measure aligns with the stipulations outlined in the Pakistan Stock Exchange (PSX) Regulation 5.6.4.

According to information available from the Pakistan Stock Exchange (PSX), the announcement of the Closed Period is a standard procedure intended to maintain transparency and integrity while the board reviews the financial outcomes.

BF Biosciences Limited operates within the pharmaceutical sector, a designated market category known for its critical contributions to healthcare and medicine. The upcoming board meeting is anticipated to shed light on the company's financial health and strategic direction for the coming year.